CNX Therapeutics to expand CNS portfolio through the acquisition of two established brands from Sanofi
CNX Therapeutics to expand CNS portfolio through the acquisition of two established brands from Sanofi London, 1 December, 2023 - CNX Therapeutics Limited (“CNX Therapeutics”), a speciality pharmaceutical company with a focus on improving access to medicines that are critical to the well-being of pa...